Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Jul 20;24(21):3490-6.
doi: 10.1200/JCO.2005.03.6236.

Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer

Robin Matsuyama  1 , Sashidhar Reddy, Thomas J Smith
Affiliations
Review

Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer

Robin Matsuyama et al. J Clin Oncol. .

Abstract

Purpose: The number of patients receiving chemotherapy near the end of life is increasing, as are concerns about goals of treatment, toxicity, and costs. We sought to determine the available sources of knowledge, the choices, and concerns of actual patients, and how patients balanced competing issues.

Methods: We used a literature search from 1980 to present.

Results: Available patient sources provide little information about prognosis, choices, alternatives, consequences, or how to choose. Many patients would choose chemotherapy for a small benefit in health outcomes, and for a smaller benefit than perceived by their health care providers for their own treatment. Adverse effects are less a concern for patients than for their well health care providers. There are no decision aids to assist patients with metastatic disease in making their choices, such as there are for adjuvant breast therapy.

Conclusion: The perspective of the patient is different from that of a well person. Patients are willing to undergo treatments that have small benefits with major toxicity. Receiving realistic information about the different options of care and the likelihood of successful treatment or adverse effects is difficult. These factors may explain some of the increased use of chemotherapy near the end of life. Decision aids and honest, unbiased sources to inform patients of their prognosis, choices, consequences, typical outcomes, and ways to make decisions are needed. More prospective information about how patients make their choices, and what they would consider a good choice, would assist informed decision making.

PubMed Disclaimer

Comment in

  • Do unto others..
    Earle CC. Earle CC. J Clin Oncol. 2006 Jul 20;24(21):3331-2. doi: 10.1200/JCO.2006.06.7561. J Clin Oncol. 2006. PMID: 16849746 No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

  NODES
admin 1
todo 1
twitter 2